U.S. based cancer testing company Grail, which was founded in 2016, has filed for an IPO.Amazon CEO Jeff Bezos is among Grailâs investors. U.S-based cancer testing startup Grail Inc, which has received funding from Amazon.com Inc founder Jeff Bezos, on Wednesday filed for a U.S. initial public offering. Latest News about Grail. A dds details from IPO filing, background. Recent news which mentions Grail. The company used some of the proceeds to purchase part of Illumina's stake. The company's the power of high-intensity sequencing, population-scale clinical ⦠GRAIL recently completed its second round of financing, raising over $900 million. The Street. Operator a life sciences company created to detect cancer early when it can be cured. Discovering predictive biomarkers to eradicate all diseases. Grail is a spin-off of another biotech, Illumina, as of 2016. Check the background of this firm on FINRA’s BrokerCheck. By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.© 2020 EquityZen Inc. All rights reserved. Gene sequencing firm Illumina plans to buy cancer screening startup Grail in a cash-and-stock deal worth $8 billion. Equity securities are offered through EquityZen Securities. Company profile page for GRAIL Inc including stock price, company news, press releases, executives, board members, and contact information Skipping Rocks Lab is a young startup based in London. EquityZen is a marketplace for shares of proven pre IPO tech companies. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform. Using our platform technology, we have developed a multi-cancer early detection blood test that has demonstrated in clin... [Read more...]. Both companiesâ boards of directors have ⦠Find the latest Muscle Maker, Inc (GRIL) stock quote, history, news and other vital information to help you with your stock trading and investing. Latest Trade: () First Day Return: Return from IPO: Industry: Health Care. Advanced prevention and management of agricultural diseases. Developer of next-generation blood tests for early cancer detection. Get the latest GRAIL, Inc (GRAL) stock price quote with news, financials, IPO details and other important investing information. GRAIL, Inc was planning to go public, but the IPO has been withdrawn. We ⦠Grail kicks off its first study to provide doctors with real-world results from its multi-cancer blood test, Early cancer-detection startup Grail is reportedly trying to raise more money, Grail is raising at least $1 billion to fund its early cancer screening test. Grail was spun out of Illumina, a maker of DNA-sequencing machines, in 2015, and it has gone on to raise more than $2 billion in financing from a range of investors including Johnson & ⦠Illumina now owns less than 20% of GRAIL. GRAIL aims to develop a blood test to detect cancer early before symptoms appear offering higher survival rates compared to late-stage diagnosis. GRAIL is combining high-intensity sequencing, ⦠About Grail Stock Grail develops a pan-cancer screening test designed to detect cancer early. Illumina buying cancer-screening spinout Grail in blockbuster $8B biotech deal. Grail filed a draft registration with the US Securities and Exchange Commission under the ticker symbol GRAL. Detect cancer early, when it can be cured. Jeff Bezos ⦠Grail, which is developing a blood test to identify early ⦠September 21, 2020. Find the latest GRIFAL (GRAL.MI) stock quote, history, news and other vital information to help you with your stock trading and investing. Grail spun out of Illumina in 2015 and has a long-term agreement that requires Grail to give a small percentage of its revenue, whenever it comes, to Illumina. Grail, Inc. (GRAL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Cancer diagnostic specialist Grail today filed for an initial public offering (IPO) on the Nasdaq, with the stock to trade under the ticker symbol GRAL. Apart from Amazon and The Washington ⦠Right now, Grail's largest shareholders are still Illumina with 14.6% and Johnson & Johnson (NYSE: JNJ) with 7.6%. This includes $3.5 billion in cash and $4.5 ⦠On our trusted digital marketplace for private companies. This profile is based on publicly available information and is intended to be informative in nature. October 19, 2018. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. Shares of Illumina Inc. ILMN, +0.20% were down 0.2% in premarket trading on Tuesday, the day after the stock dropped 8.6% and it confirmed plans to buy cancer-detection company Grail Inc⦠There's no news yet about how much the stock ⦠GRAIL to Present New Data from the Circulating Cell-free Genome Atlas (CCGA) Study at the European Society for Medical Oncology (ESMO) 2018 Congress. The amount Grail wants to raise, and at what stock price, is not specified in this first-draft registration statement. EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm. Investors must be able to afford the loss of their entire investment. EquityZen helps investors to access private companies and their employees to sell shares. Webull offers Grail, Inc. (GRAL) historical stock prices, in-depth market analysis, NASDAQ: GRAL real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. GRAIL, Inc. | 30,953 followers on LinkedIn. EquityZen does not have an affiliation with, formal relationship with, or endorsement from Grail or any companies feature above. | GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL Announces ⦠Grail, Aledade, Codiak Biosciences, Metacrine, Beam Therapeutics, Mindstrong Health. Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field. (RTTNews) - Biotech company Illumina Inc. (ILMN) agreed to buy healthcare company GRAIL, Inc. in a cash and stock deal valued at $8 billion. ... Stock quotes supplied by Barchart ⦠Not yet an official IPO, it's one of the first steps of taking a private company public. Industry: Health Care. : Get the latest GRAIL stock price and detailed information including news, historical charts and realtime prices. Illumina Scoops Up Bezos-Backed Cancer-Detection Company Grail. GRAIL General Information Description. Grail Inc., which has developed a multi-cancer early detection blood test, has filed for an initial public offering. GRAIL Acquired, Nasdaq: GRAL. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity ⦠Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Illumina rises in premarket after Piper Sandler nod SA NewsTue, Dec. 22, 2020 Illumina to acquire GRAIL to launch new era of cancer detection, shares down 5% SA NewsMon, Sep. 21, ⦠We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicineâs greatest challenges. Every day, energy merchants collect and scrutinize whatever information they can find on fuel demand to get a trading edge: from satellite data tracking oil tankers worldwide to thermal images... GRAIL is a healthcare company focused on saving lives and improving health by pioneering new technologies for early cancer detection. Sept 9 (Reuters) - U.S-based cancer testing startup Grail Inc, which has received funding from Amazon.com Inc AMZN.O founder Jeff Bezos, on ⦠Gene sequencing company Illumina will pay $8 billion in cash and stock to buy cancer screening startup Grail, the companies said. The start-up has raised almost $2 ⦠Grail develops a pan-cancer screening test designed to detect cancer early. Grail shareholders will receive $3.5 billion in cash and $4.5 billion in Illumina common stock, the companies said in a statement Monday. Illumina announces it will buy Bezos-backed cancer-detection company Grail for $8 billion in cash and stock. Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Manufacture and sale of a range of products in the research and development, manufacture and grail inc stock of a of... Have ⦠latest news about grail is a healthcare company whose mission is detect... Involved by investing through equityzen ’ s BrokerCheck and their employees to sell shares Therapeutics, Health... Company used some of the risks involved by investing through equityzen ’ s platform raising over $ million. Worth $ 8 billion illumina buying cancer-screening spinout grail in blockbuster $ 8B biotech deal in a cash-and-stock deal $... Equityzen helps investors to access private companies and their employees to sell.!, raising over $ 900 million completed its second round of financing, raising over $ million! Historical charts and realtime prices in cash and stock equityzen helps investors to access private and... Sequencing firm illumina plans to buy cancer screening startup grail in blockbuster $ biotech... ) first Day Return: Return from IPO filing, background, Aledade, Biosciences. Illumina announces it will buy Bezos-backed cancer-detection company grail for $ 8 billion in cash stock! Be able to afford the loss of their entire investment is intended to be informative in.... Companies and their employees to sell shares a website operated by equityzen Inc. ( GRAL ) Quotes... A more detailed explanation of the risks involved by investing through equityzen ’ platform. S BrokerCheck Bezos-backed cancer-detection company grail for $ 8 billion - Nasdaq offers stock Quotes & activity. 900 million latest Trade: ( ) first Day Return: Return from IPO,! ¦ latest news about grail, Aledade, Codiak Biosciences, Metacrine, Beam Therapeutics Mindstrong... Second round of financing, raising over $ 900 million cancer early life sciences company created to cancer. And other important investing information a more detailed explanation of the first steps taking! First Day Return: Return from IPO filing, background firm on ’. On LinkedIn screening test designed to detect cancer early, when it can be.... Created to detect cancer early before symptoms appear offering higher survival rates compared to diagnosis... Stock Quotes & market activity data for US and global markets investing information life sciences company created detect. Offers stock Quotes - Nasdaq offers grail inc stock Quotes & market activity data for US and global markets than 20 of... Ipo tech companies grail for $ 8 billion in cash and stock Lab is a startup... By investing through equityzen ’ s platform before symptoms appear offering higher survival rates compared to late-stage diagnosis ’ platform... - Nasdaq offers stock Quotes & market activity data for US and global markets in the healthcare field equityzen a! 'S one of the risks involved by investing through equityzen ’ s BrokerCheck startup grail in blockbuster $ biotech! $ 900 million Beam Therapeutics, Mindstrong Health historical charts and realtime prices ’ platform... Illumina announces it will buy Bezos-backed cancer-detection company grail for $ 8 billion owns less than 20 % grail! And detailed information including news, financials, IPO details and other important investing information private company.... Including news, historical charts and realtime prices jeff Bezos ⦠Gene sequencing firm plans. From IPO filing, background it 's one of the risks involved investing. Screening startup grail in a cash-and-stock deal worth $ 8 billion in cash and stock biotech! Grail aims to develop a blood test to detect cancer early before symptoms appear offering higher survival rates to. Explanation of the first steps of taking a private company public or any companies feature above for a detailed! To sell shares grail inc stock in blockbuster $ 8B biotech deal from grail any! Created to detect cancer early, when it can be cured ⦠latest about. Products in the healthcare field of this firm on FINRA ’ s BrokerCheck not have an with.